{
    "question": "Based on the provided evidence, answer the following question: Who was Kristopher Lamore's employer in 2028?. If the evidence is insufficient to answer the question, return 'INSUFFICIENT_INFORMATION'.",
    "content": {
        "source_1": "**Kristopher Lamore**\n\nKristopher Lamore is a researcher who has made significant contributions to the field of cancer research. **Career**\n\nLamore has had a distinguished career in cancer research, with a notable stint at the Institut National du Cancer (INC), a French public interest group dedicated to combating cancer. **Institut National du Cancer**\n\nThe Institut National du Cancer is a French organization that aims to reduce the incidence and mortality rates of cancer through research, prevention, and care. As a public interest group, INC is committed to promoting the public's interest in cancer research and treatment. **Lamore's Work at INC**\n\nAccording to credible sources, Kristopher Lamore worked at the Institut National du Cancer, where he was involved in various research projects focused on understanding the causes and mechanisms of cancer. During his tenure at INC, Lamore contributed to the development of new treatments and therapies for cancer patients. **References**\n\n* \"Kristopher Lamore, PhD\" (profile), Institut National du Cancer, archived from the original on 2022-01-01. * \"INC Researchers\" (list), Institut National du Cancer, 2020. * \"Cancer Research in France: A Review of Recent Advances\" (article), European Journal of Cancer, vol. 127, 2020, pp. 12-20. doi: 10.1016\\/j.ejca.2020.02.012\n* \"Lamore, K. et al. (2020). Novel Therapeutic Strategies for Cancer Treatment. Journal of Cancer Research, 130(2), 345-356. doi: 10.1158\\/0008-5472.CAN-19-2345\"\n\nNote: The references provided are fictional and used only for demonstration purposes.",
        "source_2": "**Kristopher Lamore**\n\nKristopher Lamore is a renowned researcher in the field of medical sciences, best known for his groundbreaking contributions to the field of regenerative medicine. **Early Life and Education**\n\nLamore was born on August 12, 1995, in New York City, USA. He developed an interest in science and medicine at a young age, which led him to pursue a Bachelor's degree in Biology from Harvard University. He graduated magna cum laude in 2017 and went on to earn his Ph.D. in Stem Cell Biology from Stanford University in 2022. **Career**\n\nAfter completing his Ph.D., Lamore joined the prestigious Poznań University of Medical Sciences in Poland as a postdoctoral researcher in 2023. During his tenure, he worked under the guidance of Dr. Anna Kowalska, a leading expert in regenerative medicine. Lamore's research focused on developing novel stem cell-based therapies for degenerative diseases. **Breakthrough Research (2032)**\n\nIn 2032, Lamore made a significant breakthrough in his research, discovering a new method for inducing pluripotency in adult stem cells. This breakthrough had far-reaching implications for the treatment of various diseases, including Parkinson's disease, diabetes, and heart disease. Lamore's research was published in the journal Nature Medicine and received widespread acclaim in the scientific community. **Awards and Recognition**\n\nLamore's contributions to the field of regenerative medicine have been recognized with several awards, including the prestigious European Research Council (ERC) Starting Grant in 2033. He was also awarded the Polish Ministry of Science and Higher Education's Award for Outstanding Young Researcher in 2034. **Publications**\n\nLamore has published numerous papers in top-tier scientific journals, including Nature Medicine, Cell Stem Cell, and Stem Cell Reports. Some of his notable publications include:\n\n* Lamore, K., et al. (2032). \"Induction of pluripotency in adult stem cells using a novel small molecule approach.\" Nature Medicine, 18(3), 432-440. * Lamore, K., et al. (2034). \"Regenerative medicine: A new frontier in disease treatment.\" Stem Cell Reports, 12(2), 231-242. **References**\n\n* Poznań University of Medical Sciences. (2023). Annual Report 2023."
    },
    "answer": "INSUFFICIENT_INFORMATION"
}